Evaluation of the change in efficacy of erenumab when used long ‐term for migraine prevention after initial established benefit in a Veteran population
ConclusionsA decrease in efficacy with long-term use of erenumab was observed for the majority of patients evaluated in this analysis. This suggests that patients with initial benefit on lower dose erenumab should be monitored for change to effectiveness.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Alison W. Martin,
Mara Cubellis Tags: RESEARCH ARTICLE Source Type: research
More News: Brain | Drugs & Pharmacology | Genetics | Headache | Migraine | Neurology | Statistics | Study